Professional Skin Care Company Orthoneutrogena Becomes Ortho Dermatologics
New Identity Reflects Company’s Complete Portfolio Of Rx And Specialty Aesthetic Products
Titusville, NJ.-Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today that its OrthoNeutrogena division is now Ortho Dermatologics.
The new name and identity reflect the company’s dedication to professional skin care and skin health, better representing its entire portfolio of prescription and specialty aesthetic products for medical dermatology and aesthetic medicine.
With an expansive heritage of excellence and innovation in dermatology-based solutions and more than 30 years of experience in meeting the needs of physicians, Ortho Dermatologics offers a complete line of proven anti-aging, anti-acne, anti-fungal, post-procedure care and specialty aesthetic brands that work to restore health and beauty to the skin. Ortho Dermatologics brands include RETIN-A MICRO® (tretinoin gel) microsphere, 0.04% and 0.1%, ERTACZO® (sertaconazole nitrate) cream, 2%, RENOV® (tretinoin cream) 0.02% and BIAFINE®, as well as the company’s new medical device, the advanced collagen dermal filler, EVOLENCE®.
"Our new company name and identity underscore our devotion to the future of medical dermatology and aesthetic medicine,” says Robert Coradini, President, New Ventures, Johnson & Johnson Consumer Products Company. “We provide medical dermatologists and aesthetic physicians with exceptional products based on science and proven clinical outcomes that help them to continually exceed their patients’ expectations and are committed to evolving our offerings to reflect the changing needs of physicians and consumers,” adds Coradini.
No changes will be made to the company’s sales force or operations and the new name and identity are effective immediately.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.